CD40LG and neoplasm: Through subcutaneous injection of original MB49 cells, in vivo selection/enrichment, and primary tumor cell culturing, we collected faster growing MB49 tumor cells to evaluate the therapeutic effects of BV-CD40L and BV-IL15 (see Supplementary Information).